Gurney, Jodi P.,Zhang, Xiaokui,Herb, Stacy,Hariri, Robert J.
申请号:
AU2020202182
公开号:
AU2020202182A1
申请日:
2020.03.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020202182A120200416.pdf#####ASBTRACT Provided herein are compositions comprising mononuclear cells from human placental perfusate and methods of using such cells, including using the cells together with hematopoietic cells, for example to establish chimerism, reduce the severity or duration of graft versus host disease, treat or ameliorate symptoms of sarcopenia, metabolic disorders and hematologic disorders, such as hematologic malignancies, and treat or ameliorate symptoms of ischemic encephalopathy (e.g., hypoxic ischemic encephalopathy) and other central nervous system injuries.